Cytek Biosciences Inc
NASDAQ:CTKB
Income Statement
Earnings Waterfall
Cytek Biosciences Inc
Revenue
|
193m
USD
|
Cost of Revenue
|
-83.6m
USD
|
Gross Profit
|
109.4m
USD
|
Operating Expenses
|
-137.3m
USD
|
Operating Income
|
-27.8m
USD
|
Other Expenses
|
15.7m
USD
|
Net Income
|
-12.1m
USD
|
Income Statement
Cytek Biosciences Inc
Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||
Revenue |
89
N/A
|
128
+44%
|
139
+8%
|
148
+7%
|
155
+4%
|
164
+6%
|
166
+1%
|
176
+6%
|
183
+4%
|
193
+5%
|
|
Gross Profit | |||||||||||
Cost of Revenue |
(34)
|
(49)
|
(54)
|
(59)
|
(59)
|
(63)
|
(64)
|
(70)
|
(77)
|
(84)
|
|
Gross Profit |
56
N/A
|
79
+42%
|
85
+7%
|
90
+6%
|
95
+6%
|
101
+6%
|
102
+1%
|
105
+4%
|
106
+0%
|
109
+3%
|
|
Operating Income | |||||||||||
Operating Expenses |
(48)
|
(70)
|
(79)
|
(89)
|
(96)
|
(103)
|
(113)
|
(125)
|
(133)
|
(137)
|
|
Selling, General & Administrative |
(30)
|
(45)
|
(52)
|
(59)
|
(64)
|
(68)
|
(77)
|
(85)
|
(90)
|
(93)
|
|
Research & Development |
(17)
|
(24)
|
(27)
|
(30)
|
(32)
|
(35)
|
(37)
|
(41)
|
(43)
|
(44)
|
|
Operating Income |
8
N/A
|
9
+20%
|
6
-40%
|
1
-83%
|
(1)
N/A
|
(2)
-216%
|
(12)
-545%
|
(20)
-71%
|
(28)
-39%
|
(28)
-1%
|
|
Pre-Tax Income | |||||||||||
Interest Income Expense |
(1)
|
(2)
|
(2)
|
(2)
|
(0)
|
2
|
4
|
5
|
5
|
4
|
|
Non-Reccuring Items |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
1
|
3
|
5
|
7
|
8
|
|
Pre-Tax Income |
6
N/A
|
6
+7%
|
2
-58%
|
(2)
N/A
|
(2)
-11%
|
1
N/A
|
(4)
N/A
|
(10)
-116%
|
(16)
-62%
|
(16)
+0%
|
|
Net Income | |||||||||||
Tax Provision |
(1)
|
(3)
|
(2)
|
(0)
|
0
|
1
|
2
|
4
|
2
|
4
|
|
Income from Continuing Operations |
4
|
3
|
1
|
(3)
|
(2)
|
3
|
(2)
|
(6)
|
(14)
|
(12)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
Net Income (Common) |
0
N/A
|
0
N/A
|
(2)
N/A
|
(2)
-12%
|
(1)
+58%
|
3
N/A
|
(2)
N/A
|
(6)
-171%
|
(14)
-136%
|
(12)
+14%
|
|
EPS (Diluted) |
0
N/A
|
0
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
0.02
N/A
|
-0.02
N/A
|
-0.05
-150%
|
-0.11
-120%
|
-0.09
+18%
|